Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ACOR

Acorda Therapeutics (ACOR)

Acorda Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACOR
DateTimeSourceHeadlineSymbolCompany
04/15/20244:03PMBusiness WireAcorda Therapeutics Announces Delisting from NasdaqNASDAQ:ACORAcorda Therapeutics Inc
04/03/20244:30PMBusiness WireAcorda Therapeutics Announces Nasdaq Delisting NotificationNASDAQ:ACORAcorda Therapeutics Inc
04/01/20245:35PMBusiness WireAcorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase AgreementNASDAQ:ACORAcorda Therapeutics Inc
04/01/20243:01PMBusiness WireAcorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
03/25/20243:01PMBusiness WireAcorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024NASDAQ:ACORAcorda Therapeutics Inc
01/11/20247:33AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
01/11/20247:01AMBusiness WireAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025NASDAQ:ACORAcorda Therapeutics Inc
12/01/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
11/13/20233:16PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
11/13/20233:01PMBusiness WireAcorda Therapeutics Reports Third Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
11/06/20233:01PMBusiness WireAcorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023NASDAQ:ACORAcorda Therapeutics Inc
11/06/20237:00AMBusiness WireAcorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®NASDAQ:ACORAcorda Therapeutics Inc
08/08/20233:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACORAcorda Therapeutics Inc
08/08/20233:01PMBusiness WireAcorda Therapeutics Reports Second Quarter 2023 Financial ResultsNASDAQ:ACORAcorda Therapeutics Inc
08/02/20237:00AMBusiness WireAcorda Therapeutics Announces Launch of New INBRIJA® Campaign: “For The Fighters™”NASDAQ:ACORAcorda Therapeutics Inc
08/01/20237:00AMBusiness WireAcorda Second Quarter 2023 Update: Webcast/Conference Call Scheduled for August 8, 2023NASDAQ:ACORAcorda Therapeutics Inc
06/28/20234:08PMBusiness WireTom Burns Elected to the Acorda Therapeutics Board of DirectorsNASDAQ:ACORAcorda Therapeutics Inc
06/26/20233:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
06/26/20237:23AMBusiness WireAcorda Therapeutics Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
06/26/20237:00AMBusiness WireAcorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price RequirementNASDAQ:ACORAcorda Therapeutics Inc
06/23/20234:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
06/23/20234:38PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
06/23/20234:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
06/23/20234:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACORAcorda Therapeutics Inc
06/02/20233:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
06/02/20233:01PMBusiness WireAcorda Therapeutics Announces Completion of 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
06/01/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
05/31/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACORAcorda Therapeutics Inc
05/31/20233:01PMBusiness WireAcorda Therapeutics to Conduct 1-for-20 Reverse Stock SplitNASDAQ:ACORAcorda Therapeutics Inc
05/30/20237:00AMBusiness WireAcorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&ANASDAQ:ACORAcorda Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ACOR